Ectodermal dysplasia syndromes a r e associated with varying degrees of c e l l u l a r immune defects. TWO male s i b l i n g s with anhyd r i t i c ectodermal dysplasia (AED) succumbed t o generalized atypic a l tuberculosis infections. The second child had recurrent bact e r i a l infections a s well and is the subject of t h i s report. At age 10 years skin anergy t o multiple antigens was present when 3. i n t r a c e l l u l a r e was isolated from bone marrow, spleen, l i v e r and multiple lymph nodes. Evaluation of immune function included T and B c e l l enumeration, mitogen and antigen stimulation, MIF production, serum immunoglobulin and s p e c i f i c antibody production, PMN and macrophage phagocytosis, k i l l i n g and chemotaxi8, and lymphocyte interferon production. General anergy and depressed PMN and macrophage chemotaxis varied i n d i r e c t l y with positive responses t o antimicrobial therapy. P e r s i s t e n t abnormal responses included no skin t e s t o r i n v i t r o lymphocyte response t o g. t b o r g. i n t r a c e l l u l a r e , abnormal macrophage morphology, poor -granulomata formation, and absent interferon (In production. Pat i e n t lymphocytes f a i l e d t o produce I F even a f t e r contact with normal macrophages. Although normal lymphoid t i s s u e was present a t diagnosis, no lymphoid t i s s u e was present a t post mortem. Afferent and e f f e r e n t defects i n immune function appear t o be responsible f o r t h i s f a t a l i l l n e s s . Further study of t h i s a x i s i n recovery from tuberculosis and i n AED may elucidate the primary o r secondary nature of such defects.
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COMBINED CMV-EBV INFECTION TREATED WITH ORAL TRANSFER
1034 FACTOR (OTF) . James F . Jones, Linda Minnich, Wayburn J e t e r , and Vincent A. F u l g i n i t i , Univ. of Arizona, Departments of Pediatrics, Pathology and Microbiology, Tucson.
A 4-year old male had recurring episodes of a r t h r i t i s , skin rash, abdominal pain, vomiting and a t y p i c a l lymphocytosis f o r 1% years following an acute i l l n e s s i n Jan. 1978 t h a t included pharyngitis. No etiology was found during the f i r s t 2 months of illness; f u r t h e r serological t e s t i n g i d e n t i f i e d the probable cause . CMV was present i n a buffy coat culture during an episode i n Nov. 1978. Although C M V t i t e r s were p e r s i s t e n t l y increased, i n v i t r o lymphocyte responses t o CMV remained negative (SI <1.0; control >3.0); responses t o mitogen were normal. A 7-month t r i a l of levamisole was ineffective. Bovine OTF from an animal skin t e s t positive t o infectious rhinotracheitis virus (cross r e a c t s with human CMV) was administered every three weeks f o r 6 months. Two months a f t e r s t a r t i n g OTF, symptoms and v i r u r i a ceased and C M V SI was 4.0. He has remained symptom-free with a continued positive SI f o r 1 year without further therapy. Recovery from t h i s chronic C M V infection was temporally related t o OTF administration. Further evaluation of treatment with OTF f o r chronic v i r u s infection accompanied by abnormal c e l l u l a r immunity is suggested. Because factors influencing the imune response t o streptococc a l M protein following upper respiratory t r a c t (URT) and skin infections are poorly understood, we evaluated epidemiologic data from 4 groups of p a t i e n t s (408 s e r i a l l y collected s e r a from 119 children; iii age = 6.5 yrs.) followed carefully f o r 2 yrs. The date and s i t e of f i r s t acquisition of 4 serotypes (6,31,49,52), and the type-specific serum b a c t e r i c i d a l a c t i v i t y (SBA) from preand post-acquisition s e r a were determined. The effects of p a t i e n t age, serotype, s i t e of isolation and number of culturepositive v i s i t s f o r each M type on the development of SBA were studied.
FACTORS INFLUENCING DEVELOPMENT OF GROUP
M-6 was i s o l a t e d from only the URT; while M-31, 49, and 52 were i s o l a t e d from both skin and URT. Significant SBA developed i n 27 of 41 (66%) p a t i e n t s with M-6: 22 of 41 (54%) with M-31; 13 of 31 (42%) with M-49; and 4 of 6 (67%) with M-52. The magnitude of the SBA response was generally g r e a t e r f o r those with I M-6. Of those with M-31 o r M-49, no difference i n SBA was noted between those with recovery only from t h e URT and those with recovery from both the URT and skin lesions. The development of SBA was r e l a t e d t o number of i s o l a t i o n s , although d i f f e r e n t f o r those acquiring each type. The increase i n SBA was age-related i n those with M-6, but not i n those with M-31 o r M-49. These data define several complex variables which may influence development of SBA following group A streptococcal infections. The e f f e c t of bacterial infection on PMN CX has not been studied i n d e t a i l . Whether infection causes impairment o r enhancement i s controversial. The response during infection, t o chemot a c t i c factors (CF) generated by the pathogen i s unknown. 14 patients (mean age 4.5 y r s ) and 14 age matched controls were studied. 4 had septicemia; 1 meningitis; 5 UTI, 6 E n t e r i t i s and 1 o t i t i s media. The organisms isolated (Pneumococcus, Shigella, Pseudomonas, E. col i , Klebsiel l a and Salmonel l a ) were grown i n broth. CF f o r each organism (OCF) was obtained. 12 patients were studied before and 2 during a n t i b i o t i c therapy. CX was performed u t i l i z i n g Boyden's technique. PMNS placed on 3 p micropore f i l t e r were tested against OCF, endotoxin activated serum (EAS) and an standard E. coli CF (ECF) t o determine chemotactic index (CI) and against Hank's solution random migration (RM). The mean (5 1SD) CI and RM a r e presented ( t a b l e ) . CI obtained with These findings suggest t h a t the invading organism contributes t o the h o s t ' s vulunerabi 1 i t y and may impair recovery by decreasing CX.
THE EFFECT(s) OF FACTOR(s) GENERATED BY INVADING PATHOGENS ON CHEMOTAXIS (CX) OF HOST NEUTROPHILS (PMNS
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